Multinational pharmaceutical companies : principles and practices /
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
New York :
Raven Press,
1994
|
| Edition: | Second edition. |
| Subjects: |
Table of Contents:
- Overview of a pharmaceutical company and the industry
- Pharmaceutical industry: definitions
- Big picture
- Standards
- Mergers, joint ventures and alliances
- Pharmacopolitics
- Institutional memory
- Keys for pharmaceutical success
- Corporate organization and management issues
- Models of international operations
- Organization at the corporate level
- Corporate management
- Enhancing communication
- Personnel issues
- Golden rules of staffing
- Conflicts of interest
- Crisis management
- Differences between pharmaceutical companies
- Future environments for medicine discovery and development
- Medicine discovery and development
- Overview of factors affecting medicine discovery
- Medicine discovery process
- Golden rules of medicine discovery
- Medicine development process
- Golden rules of medicine development
- Biotechnology
- Extrapolating animal safety data to humans
- Evaluating and interpreting data
- Stimulating innovation and increasing efficiency
- Future of medicine discovery.
- (cont) Research and development organization and management issues
- Organizing research and development
- Managing research and development
- Personnel issues in medicine discovery and development
- Balancing line function and matrix approaches
- Choosing the number of medicines to develop
- Criteria for developing medicines
- Evaluating a portfolio of investigational medicine projects
- Productivity, innovation and project success
- Medical-marketing interface
- Corporate issues regarding the medical marketing interface
- Organizational and staffing issues regarding the madical marketing interface
- Medical and marketing needs, wants, possibilities and problems in developing new medicines
- Joint medical and marketing activities
- Technical and functional issues and activities
- Information technology
- Providing product information
- Data management and statistics
- Toxicology issues
- Clinical trials
- Issues of technical development
- Marketing issues
- Licensing issues
- Regulatory affairs
- Production issues
- Patent issues
- Legal activities and issues.
- (cont) Financial issues
- Major corporate issues and challenges
- Animal testing and animal welfare
- Patient package inserts
- Patent expiration
- Switching prescription medicines to over the counter status
- Interaction with legislators and the public
- Costs and pricing
- International development
- External interactions and relationships
- Interactions and relationships with academic institutions
- Technology transfer from academia
- Interactions and relationships with government agencies
- Interactions and relationships between pharmaceutical companies: competition and collaboration
- Interactions and relationships with trade associations
- Interactions and relationships with health professionals
- Interactions and relationships with patients and the public
- Interactions and relationships with the media
- Selected books about medicine development or of particular interest to the pharmaceutical industry.
